#-supreme-cellcarta-differentiators-15-144{items-data:[{"text":"Expert Bioinformatics "},{"text":"Proprietary ML Pipelines "},{"text":"Full-Modality Coverage "},{"text":"Reproducible Pipelines"},{"text":"Regulatory-Grade QC"}]}#-supreme-cellcarta-faq-13-144{items-data:[{"faq_question":"What types of genomic data analysis does CellCarta support? ","faq_answer":"CellCarta's genomic data analysis services support every major sequencing and molecular modality used in translational and clinical programs:RNA-seq,whole genome and whole exome sequencing,quantitative and digital PCR,single-cell sequencing,spatial biology,and validated off-the-shelf assays,including TSO500,oncoReveal CDx,and Aspyre Lung. Each modality is delivered by an in-house bioinformatics team that applies rigorous QC,transparent pipelines,and advanced methods,including machine-learning–based biomarker quantification. "},{"faq_question":"What gene expression analysis capabilities does CellCarta offer for clinical biomarker programs? ","faq_answer":"CellCarta's gene expression analysis services capabilities cover RNA-seq and NanoString nCounter workflows for biomarker discovery,validation,and clinical deployment. RNA-seq pipelines include read alignment,transcript quantification,splice variant and fusion detection,tumor immune cell fraction analysis,and proprietary ML-based eTMB and eMSI quantification. NanoString workflows include background correction,normalization,batch effect control,differential gene expression,and pathway enrichment — supporting biomarker programs from translational research through late-stage clinical trials. "},{"faq_question":"Can CellCarta integrate genomic findings with other biomarker modalities,such as immunology or spatial biology? ","faq_answer":"Yes — and this is one of the clearest advantages of working with CellCarta. Our genomic data analysis services operate within an integrated multi-omic infrastructure rather than as a standalone genomics offering. Genomic findings can be correlated with immune monitoring,flow cytometry,spatial biology,histopathology,and proteomics data,all generated under a single quality framework. For complex clinical programs where cross-modal biomarker correlation drives the science,this removes the integration burden sponsors typically carry across multiple vendors."},{"faq_question":"Can CellCarta's genomic data analysis support regulatory submissions? ","faq_answer":"Yes. CellCarta's genomic data analysis services operate within a fully governed quality management system spanning GLP,CLIA,CAP,ISO 15189,and ISO 13485. Pipelines and outputs are built to support both exploratory research and regulated submissions — including primary endpoints,IVD performance studies,and companion diagnostic programs — and every output is produced under the same quality framework across our global sites."}]}#-supreme-cellcarta-featured-resources-16-144{cards-data:[{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-2.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-3.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"}]}#-supreme-cellcarta-service-blocks-45-176{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-808-scaled.jpg","image_alt":"","title":"Next-Generation Sequencing Services","description":"Precise,high-throughput analysis of genetic material with both speed and scalability. ","button_text":"Discover","button_url":"/capabilities/genomics/sequencing-services/ngs/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-525-1-scaled.jpg","image_alt":"","title":"Digital PCR (dPCR)","description":"Nucleic acid quantification with superior accuracy,precision,and sensitivity. ","button_text":"Discover","button_url":"/capabilities/genomics/digital-pcr-services/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-23-2-1-scaled.jpg","image_alt":"","title":"Quantitative PCR (qPCR) ","description":"Support for qPCR applications using off-the-shelf assays or custom,validated primers. ","button_text":"​Explore qPCR","button_url":"/capabilities/genomics/qpcr-services/","button_target":"_self"}];items-data:[{"text":"Expert Bioinformatics "},{"text":"Proprietary ML Pipelines "},{"text":"Full-Modality Coverage "},{"text":"Reproducible Pipelines"},{"text":"Regulatory-Grade QC"}];oxy-supreme-cellcarta-service-blocks-items-data:[{"text":"Expert Bioinformatics "},{"text":"Proprietary ML Pipelines "},{"text":"Full-Modality Coverage "},{"text":"Reproducible Pipelines"},{"text":"Regulatory-Grade QC"}]}#-supreme-cellcarta-tab-content-11-144{tabs-data:[{"tab_title":"Gene Expression","content_title":"","content_body":"<p>Profile transcriptomes using gene expression analysis software for <a href=\"../sequencing-services/rnaseq/\" target=\"_self\">RNAseq</a> and NanoString nCounter®. RNA-seq pipelines cover read alignment,transcript quantification,splice variant and fusion detection,tumor immune cell fractions,and proprietary ML-based eTMB and eMSI quantification.</p>\n<p>NanoString workflows include background correction,normalization,batch effect control,DGE,and pathway enrichment analysis.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Gene-Expression-tab-488.jpg","image_alt":""},{"tab_title":"Quantitative and Digital PCR Dataset ","content_title":"","content_body":"<p>Generate validated,auditable outputs for CAR-T development,viral vector quantification,and genome editing programs within CellCarta's genomic data analysis software infrastructure.</p>\n<p><a href=\"../qpcr-services/\" target=\"_self\">Quantitative PCR (qPCR)</a> workflows use peer-reviewed models for efficiency correction,error propagation,and inter-run calibration across large sample sets. <a href=\"../digital-pcr-services/\" target=\"_self\">Digital PCR (dPCR)</a> applies generalized mixed linear models for linearity and accuracy testing,delivering auditable outputs for CAR-T,viral vector quantification,and genome editing programs.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/PCR-Dataset-tab-538.jpg","image_alt":""},{"tab_title":"Whole Genome and Whole Exome Sequencing ","content_title":"","content_body":"<p>Detect variants across the full genome or coding regions with pipelines built for clinical-grade reporting. WGS by <a href=\"../sequencing-services/ngs/\" target=\"_self\">next-generation sequencing</a> covers coding and non-coding variants,SVs,CNVs,mitochondrial variants,and repeat expansions.</p>\n<p>WES captures over 95% of disease-associated variants with SNV,indel,CNV,MSI,and TMB analysis in tumor-only or paired tumor/normal settings across oncology,rare disease,and pharmacogenomics.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta-802-scaled.jpg","image_alt":""},{"tab_title":"Off-the-Shelf Assays ","content_title":"","content_body":"<p>We run validated workflows for TSO500 HT,TSO500 ctDNA v2,oncoReveal&reg;CDx,Aspyre&reg;Lung,and HLA genotyping.</p>\n<p>Each runs on its optimized platform &mdash;Illumina Connected Analytics,Pillar's RUO Suite and IVD Workstation,or Aspyre Lab &mdash;with automated QC,variant calling,annotation,and biomarker computation. ctDNA v2 detects variants at allele frequencies as low as 0.5% for MRD assessment and longitudinal monitoring.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Off-the-Shelf-Assays-tab-521.jpg","image_alt":""},{"tab_title":"Single-Cell Sequencing Analysis ","content_title":"","content_body":"<p>Resolve cellular heterogeneity and immune repertoire dynamics using the <a href=\"../sequencing-services/single-cell-sequencing/\" target=\"_self\">10x Genomics Chromium platform</a> and Cell Ranger software.</p>\n<p>The pipeline supports 5' gene expression,V(D)J,and feature barcode libraries through alignment,clustering,cell-type annotation,trajectory inference,and pathway enrichment. CellEngine extends this with flow cytometry-style visualization,tSNE/UMAP gating,and multi-patient secondary analysis.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Single-Cell-Sequencing-Analysis-tab-541.jpg","image_alt":""},{"tab_title":"Spatial Biology Datasets ","content_title":"","content_body":"<p>Map gene expression in tissue context using genomic data analysis software across our <a href=\"../../histopathology/spatial-biology/\" target=\"_self\">spatial platforms</a>,including GeoMx and Visium HD . GeoMx pipelines include ROI selection,QC,and digital pathology integration.</p>\n<p>Visium HD uses Space Ranger for spatial alignment,normalization,clustering,and domain detection. Advanced capabilities include batch correction,cell type deconvolution using reference atlases,and gene signature enrichment.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/GeoMX-DSP.png","image_alt":""},{"tab_title":"Multi-modal Analysis ","content_title":"","content_body":"<p>Combine your datasets across several fields using our in-house multi-omic analysis capabilities,enabling a more in-depth understanding of your study&rsquo;s complex biological questions.</p>\n<p>Our data analysis pipeline combines <a href=\"../sequencing-services/rnaseq/\" target=\"_self\">RNA sequencing</a> data with <a href=\"../../histopathology/spatial-biology/\" target=\"_self\">spatial transcriptomic</a> analysis and spatial proteomics,enabling multidimensional tumor profiling.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Multi-modal-Analysis-tab-305.jpg","image_alt":""}]}